| 000 | 01660 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514194147.0 | ||
| 264 | 0 | _c20040914 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6601970 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClayton, A J | |
| 245 | 0 | 0 |
_aIncidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cAug 2004 |
||
| 300 |
_a639-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
| 650 | 0 | 4 | _aReceptors, Estrogen |
| 650 | 0 | 4 | _aReceptors, Progesterone |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aDanson, S | |
| 700 | 1 | _aJolly, S | |
| 700 | 1 | _aRyder, W D J | |
| 700 | 1 | _aBurt, P A | |
| 700 | 1 | _aStewart, A L | |
| 700 | 1 | _aWilkinson, P M | |
| 700 | 1 | _aWelch, R S | |
| 700 | 1 | _aMagee, B | |
| 700 | 1 | _aWilson, G | |
| 700 | 1 | _aHowell, A | |
| 700 | 1 | _aWardley, A M | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 91 _gno. 4 _gp. 639-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6601970 _zAvailable from publisher's website |
| 999 |
_c14968570 _d14968570 |
||